Doseloop Beta

Antihypertensive medications (ACE inhibitors, ARBs, calcium channel blockers, diuretics, etc.)

medication Under review

Antihypertensive medications encompass several classes of pharmaceuticals, including angiotensin-converting enzyme (ACE) inhibitors, angiotensin receptor blockers (ARBs), calcium channel blockers (CCBs), and diuretics, designed to lower elevated blood pressure. ACE inhibitors block the enzyme that produces angiotensin II, a hormone that constricts blood vessels, while ARBs prevent angiotensin II from binding to its receptors. Calcium channel blockers inhibit calcium entry into vascular smooth muscle and cardiac cells to promote vessel relaxation, and diuretics increase urine output to reduce blood volume and sodium levels.

Research summary

AI-Generated Content: This summary was created by AI and may contain errors. Always verify with peer-reviewed sources.

Scientific evidence from large-scale randomized controlled trials and meta-analyses demonstrates that these medications effectively reduce blood pressure and lower risks of stroke, cardiovascular mortality, and all-cause mortality in individuals with hypertension. Comparisons across classes show similar overall efficacy in preventing major cardiovascular events, though specific benefits vary, such as diuretics and CCBs often outperforming ACE inhibitors in stroke prevention. Long-term data confirm sustained cardiovascular protection without significant differences in mortality rates among the primary classes.

Reported Benefits

Reported Side Effects

Related health conditions

Research showing how this habit affects specific health conditions. Always consult healthcare professionals.

May Help With

Research (3 studies)

Systematic Review

Expression of Concern: Comparative efficacy of different antihypertensive drug classes for stroke prevention: A network meta-analysis of randomized controlled trials.

PLOS ONE • 2024 • n=487076

Not specified in excerpt

RCT

Mortality and Morbidity Among Individuals With Hypertension Randomized to Initial Treatments of Chlorthalidone, Amlodipine, or Lisinopril

JAMA Network Open • 2024 • n=32804

Not specified in excerpt

Systematic Review

Calcium channel blockers versus other classes of drugs for hypertension.

Cochrane Database of Systematic Reviews • 2021

Not specified in excerpt

Community updates

No updates yet for this supplement.

Be the first to share your experience!

At a glance

Users tracking 0
Linked studies 3
Researched benefits 3
Side effects noted 1